Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza
FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza
FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza
Submitted by
admin
on June 20, 2017 - 10:53pm
Source:
Fierce Pharma
News Tags:
FDA
advisory panels
Novo Nordisk
diabetes
Victoza
Headline:
FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza
Do Not Allow Advertisers to Use My Personal information
